VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays

Expression of vascular cell adhesion molecules (VCAM) in tumors is associated with endothelial cell activation and may facilitate adherence of carcinomatous cells to the vessel wall, promoting bloodborne metastases. Expression of VCAM was investigated in 202 breast carcinomas using automated (Ventana System) and quantitative (SAMBA image analyzer) immunoperoxidase staining of frozen sections. Positive VCAM immunoreactivity was observed in 83 tumors (41%) (mean immunostained surface, 12.4%; Sg), 10.5). The mean area of immunostaining was correlated with clinical and pathologic prognotic indicators and with the immunohistochemical expression in tissue sections of various indicators of cell proliferation, metastatic potential, and drug resistance or sensitivity, evaluated according to the same method. There was no correlation of VCAM immunoreactivity with tumor size, type, or grade or with nodal status. Also, no significant correlation was observed between VCAM and MIB1/Ki67, p53, Bcl-2, E cadherin, CD44v, cathepsin D, CD31, P-gp, ER, PR, or pS2. However VCAM immunoreactivity was significantly correlated with ELAM and VLA(2) (P = .001) and VLA(3) (P = .008) expression. The results suggest that VCAM expression in breast carcinoma tissue sections is: likely not a prognostic indicator lts practical clinical relevance, if any, must be established by correlation with patients' outcomes and tumor sensitivity to drugs. Copyright (C) 1998 by W.B. Saunders Company.